[Study of Elarzone-Dausse, a new E.N.T. anti-inflammatory agent].
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy*; D010653:Phenylbutazone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D010879:Piperazines; D010653:Phenylbutazone
Etude de l'elarzone-dausse, nouvel anti-inflammatoire en O.R.L